(Q36384243)

13 August 2017

1 reference

title

Prospects for the management of non-small-cell carcinoma of the lung with monoclonal antibodies (English)

1 reference

13 August 2017

Prospects for the Management of Non-Small-Cell Carcinoma of the Lung with Monoclonal Antibodies (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

20 October 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

20 October 2022

author name string

R. Stein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1645244

20 October 2022

D. M. Goldenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1645244

20 October 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:S0012369216401030?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

https://api.elsevier.com/content/article/PII:S0012369216401030?httpAccept=text/plain

20 October 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

20 October 2022

1 reference

13 August 2017

volume

99

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

1466-1476

1 reference

Lung cancer and autocrine growth factors

13 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Genetic events in the pathogenesis of lung cancer

20 October 2022

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Oncogenes and genetic abnormalities in lung cancer

20 October 2022

3

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Continuous cultures of fused cells secreting antibody of predefined specificity

20 October 2022

4

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Monoclonal Antibodies Specific for Two Different Histological Types of Human Lung Carcinoma

20 October 2022

5

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice

20 October 2022

8

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

A murine monoclonal antibody raised against human non-small cell carcinoma of the lung.

20 October 2022

10

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Monoclonal antibodies against two human lung carcinoma cell lines

20 October 2022

11

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Membrane antigens detected on human lung carcinoma cells by hybridoma monoclonal antibody

20 October 2022

12

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation

20 October 2022

13

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Monoclonal antibody-defined human lung cell surface protein antigens

20 October 2022

15

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Intratumoral phenotypic diversity of cloned human lung tumor cell lines and consequences for analyses with monoclonal antibodies.

20 October 2022

19

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells

20 October 2022

21

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Production and characterization of rat monoclonal antibodies with an apparent specificity for certain lung cancers and their potential clinical application

20 October 2022

22

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomas

20 October 2022

27

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay

20 October 2022

29

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Human monoclonal antibodies to lung-cancer antigens

20 October 2022

30

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Human hybridomas from patients with malignant disease

20 October 2022

31

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Immunohistological characterization of human monoclonal antibody against lung cancer

20 October 2022

32

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Antibodies from EB-virus-transformed lymphocytes of lymph nodes adjoining lung cancer

20 October 2022

33

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells

20 October 2022

36

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

20 October 2022

37

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

In vivo tumor targeting of a recombinant single-chain antigen-binding protein

20 October 2022

40

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Single-chain antigen-binding proteins

20 October 2022

41

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Antigens of small-cell lung cancer. First International Workshop.

20 October 2022

42

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Towards a better definition of human leucocyte surface molecules.

20 October 2022

43

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Identification and isolation of a common tumor-associated molecule using monoclonal antibody

20 October 2022

44

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Detection of circulating adenocarcinoma-associated antigen in the sera of cancer patients with a monoclonal antibody

20 October 2022

46

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Identification of a novel serum protein secreted by lung carcinoma cells

20 October 2022

47

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies

20 October 2022

48

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Monoclonal Antibodies to Three Widely Distributed Human Cell Surface Antigens

20 October 2022

49

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Biochemical analysis of a human epithelial surface antigen: differential cell expression and processing

20 October 2022

50

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI

20 October 2022

51

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Further characterization, isolation and identification of the epithelial cell-surface antigen defined by monoclonal antibody AUA1.

20 October 2022

52

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

A spectrum of monoclonal antibodies reactive with human mammary tumor cells

20 October 2022

53

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Efficient selection of human tumor growth-inhibiting monoclonal antibodies

20 October 2022

55

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

20 October 2022

56

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues

20 October 2022

57

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibody

20 October 2022

58

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Characterization of the antigen identified by Po66. A monoclonal antibody raised against a lung squamous cell carcinoma

20 October 2022

60

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA

20 October 2022

66

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Radiolocalization of xenografted human lung cancer with monoclonal antibody 8 in nude mice

20 October 2022

70

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Radiolabeled Monoclonal Antibody 15 and Its Fragments for Localization and Imaging of Xenografts of Human Lung Cancer

20 October 2022

71

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen

20 October 2022

74

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Evaluation of primary lung cancer with indium 111 anti-carcinoembryonic antigen (type ZCE-025) monoclonal antibody scintigraphy

20 October 2022

75

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Localisation of lung cancer by a radiolabelled monoclonal antibody against the c-myc oncogene product

20 October 2022

76

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas

20 October 2022

77

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells

20 October 2022

78

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice

20 October 2022

79

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody

20 October 2022

80

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

In vivo antitumor activity demonstrated with squamous carcinoma reactive monoclonal antibody-Vinca immunoconjugates

20 October 2022

83

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Disposition of a murine monoclonal antibody vinca conjugate (KS1/4-DAVLB) in patients with adenocarcinomas

20 October 2022

84

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Monoclonal antibody-mediated detection of lung cancer antigens in serum

20 October 2022

87

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32

20 October 2022

88

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Detection of tumor-associated antigens in the sera of lung cancer patients by three monoclonal antibodies

20 October 2022

89

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy

20 October 2022

91

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells

20 October 2022

93

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

Genetically engineered antibody molecules: new tools for cancer therapy

20 October 2022

94

1 reference

https://api.crossref.org/works/10.1378/CHEST.99.6.1466

20 October 2022

Identifiers

1 reference

13 August 2017

1 reference